Cepheid Story

Cepheid -- USA Stock  

null 52.95  0.00  0.00%

Macroaxis does not monitor all media channels or aggregates social signals for Cepheid. But even though we do not provide professional-grade financial sentiment analysis on Cepheid, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Cepheid. Check also Trending Equities.
Exercise or conversion by David Persing of 3 shares of Cepheid subject to Rule 16b-3
Filed transaction by Cepheid director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Cepheid insider trading alert for exercise of common stock by David Persing, Exec VPChief MedTech Officer, on October 7, 2017. This event was filed by Cepheid with SEC on 2011-11-01. SEC Form: Changes in beneficial ownership. David Persing is currently serves as executive vice president chief medical and technology officer, director of Cepheid

Cash Floor Correlation

Click cells to compare fundamentals   View All Correlations

Story Momentum

This story impact on price volatility cannot be determined at this time. Please check this story after some time to allow current data to be analyzed.

Similar stores for Cepheid

over a week ago at www.macroaxis.com 
Exercise or conversion by Thomas Brown of 867 shares of Cepheid subject to Rule 16b-3
Macroaxis News
Filed transaction by Cepheid director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over a month ago at www.macroaxis.com 
Exercise or conversion by Kerry Flom of 2500 shares of Cepheid subject to Rule 16b-3
Macroaxis News
Filed transaction by Cepheid officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over three months ago at http://stocknewstimes.com 
Somewhat Positive Media Coverage Somewhat Unlikely to Affect Cepheid NASDAQ ...
news
Cepheid logo Press coverage about Cepheid has been trending somewhat positive this week, Accern Sentiment Analysis reports.
over three months ago at www.macroaxis.com 
Exercise or conversion by Joseph Smith of 312 shares of Cepheid subject to Rule 16b-3
Macroaxis News
Filed transaction by Cepheid officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Did you try this?

Run Idea Optimizer Now
   

Idea Optimizer

Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Hide  View All  NextLaunch Idea Optimizer

Revenue

Revenue Comparative Analysis
  Revenue 
      Cepheid Comparables 
Cepheid is currently under evaluation in revenue category among related companies. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.